Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug treatment for obesity. We need more studies in men at higher risk of coronary events.

× No keyword cloud information.

12 in total

1. Managing overweight and obese patients with particular reference to the use of drugs. Commentary on a Report of a Working Party of the Royal College of Physicians [report withdrawn].

Authors:
Journal: J R Coll Physicians Lond Date: 1997 Sep-Oct

2. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

Authors: A Tchernof; B Lamarche; D Prud'Homme; A Nadeau; S Moorjani; F Labrie; P J Lupien; J P Després
Journal: Diabetes Care Date: 1996-06 Impact factor: 19.112

3. International trial of long-term dexfenfluramine in obesity.

Authors: B Guy-Grand; M Apfelbaum; G Crepaldi; A Gries; P Lefebvre; P Turner
Journal: Lancet Date: 1989-11-11 Impact factor: 79.321

4. Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo.

Authors: M Weintraub; P R Sundaresan; M Madan; B Schuster; A Balder; L Lasagna; C Cox
Journal: Clin Pharmacol Ther Date: 1992-05 Impact factor: 6.875

Review 5. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

Authors: G M Reaven; H Lithell; L Landsberg
Journal: N Engl J Med Date: 1996-02-08 Impact factor: 91.245

6. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors: W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal: Lancet Date: 2000 Dec 23-30 Impact factor: 79.321

7. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors: H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal: N Engl J Med Date: 1999-08-05 Impact factor: 91.245

8. Treatment of obesity: need to focus on high risk abdominally obese patients.

Authors: J P Després; I Lemieux; D Prud'homme
Journal: BMJ Date: 2001-03-24

9. Epidemiology of coronary heart disease: the Framingham study.

Authors: W P Castelli
Journal: Am J Med Date: 1984-02-27 Impact factor: 4.965

10. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.

Authors: E Reisin; R Abel; M Modan; D S Silverberg; H E Eliahou; B Modan
Journal: N Engl J Med Date: 1978-01-05 Impact factor: 91.245

4 in total

Drug treatment for obesity. We need more studies in men at higher risk of coronary events.